BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aarti Drugs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524348
ISIN Demat
INE767A01016
Book Value (Rs)
136.1848045
NSE Symbol
AARTIDRUGS
Divident Yield %
0.2
Market Cap
(Rs In Cr.)
4,480
P/E (TTM)
28.48
EPS (TTM)
17.11
Face Value
(Rs)
10
Back
Aarti Drugs consolidated net profit rises 32.70% in the March 2025 quarter
06-May-25   Hrs IST

Net profit of Aarti Drugs rose 32.70% to Rs 62.86 crore in the quarter ended March 2025 as against Rs 47.37 crore during the previous quarter ended March 2024. Sales rose 9.16% to Rs 676.76 crore in the quarter ended March 2025 as against Rs 619.99 crore during the previous quarter ended March 2024.

For the full year,net profit declined 1.90% to Rs 168.16 crore in the year ended March 2025 as against Rs 171.42 crore during the previous year ended March 2024. Sales declined 5.60% to Rs 2387.03 crore in the year ended March 2025 as against Rs 2528.58 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales676.76619.99 9 2387.032528.58 -6
OPM %13.7913.84 -12.0312.52 -
PBDT86.0477.76 11 267.56286.97 -7
PBT71.1664.18 11 211.78235.52 -10
NP62.8647.37 33 168.16171.42 -2

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)